Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000286617

Medchemexpress LLC Thalidomide-5-O-C3-NH2 hydrochloride | 2694727-94-9 | MFCD34475114 | 99.1% | 367.78 g/mol | C16H18ClN3O5 | 10 MG
SDP

Catalog No. 5000286617
Encompass_Preferred

Thalidomide-5-O-C3-NH2 hydrochloride is a thalidomide-derived cereblon (CRBN) ligand supplied as the hydrochloride salt for use as a building block in targeted protein degradation research and PROTAC design. It is provided as a solid with supporting analytical data for research use.

  • Acts as a cereblon-binding ligand for CRBN recruitment.
  • Enables linker conjugation for PROTAC assembly.
  • Supplied with high purity (99.08%).
  • Provided as a solid suitable for long-term storage under recommended conditions.
  • Analytical data and COA available to support research use.

Catalog No. 50-002-86617 Supplier Medchemexpress LLC Supplier No. HY14956010MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Thalidomide-5-O-C3-NH2 hydrochloride is a thalidomide-derived cereblon (CRBN) ligand supplied as the hydrochloride salt for use as a building block in targeted protein degradation research and PROTAC design. It is provided as a solid with supporting analytical data for research use.

  • Acts as a cereblon-binding ligand for CRBN recruitment.
  • Enables linker conjugation for PROTAC assembly.
  • Supplied with high purity (99.08%).
  • Provided as a solid suitable for long-term storage under recommended conditions.
  • Analytical data and COA available to support research use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.